NexGel, Inc Warrant NXGLW

Competitive advantage analysis · healthcare

Medical Devices & Diagnostics
Overall moat score
38/100
Developing

About NexGel, Inc Warrant

NEXGEL, Inc. manufactures and sells high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels for wound care, medical diagnostics, transdermal drug delivery, and cosmetics in the United States. It operates through two segments: Nexgel and CG labs. The company offers over-the-counter remedy solutions, such as blister and pain applications; and beauty and cosmetic solutions. It also developing … Full NXGLW analysis →

Competitive advantage assessment

Key strengths

  • Improving FCF Trend FCF trend score is positive (score 0.87). Improving FCF margin signals compounding operational leverage.
  • Expanding Operating Margin Operating margin trend is positive (score 0.89). Margin expansion confirms commercial leverage is building.

Key risks

  • Below-Peer Gross Margins Gross margin quality lags peers (score 0.36). May indicate commodity-like product mix or distributor margin drag.
  • Weak Capital Return Profile Capital return quality is below peers (score 0.28). Low ROIC raises questions about M&A discipline and pipeline ROI.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Developing
26

Where NXGLW ranks in Medical Instruments & Supplies

NexGel, Inc Warrant ranks #43 of 62 scored companies in Medical Instruments & Supplies by moat score — the top 69%. The widest moat in the group is Intuitive Surgical, Inc. (ISRG) at 86/100.

Moat scores for companies ranked near NXGLW in Medical Instruments & Supplies
# Company Moat score Rating
39 Milestone Scientific, Inc. MLSS 40/100 Developing
40 Microbot Medical Inc. MBOT 39/100 Developing
41 JIN MEDICAL INTERNATIONAL LTD. ZJYL 39/100 Developing
42 NexGel, Inc NXGL 38/100 Developing
43 NexGel, Inc Warrant NXGLW 38/100 Developing
44 Harvard Bioscience, Inc. HBIO 37/100 Developing
45 LUCY LUCY 35/100 Developing
46 Bionano Genomics, Inc. BNGO 35/100 Developing
47 Anteris Technologies Global Cor AVR 34/100 Developing

See every Medical Devices & Diagnostics company ranked by moat score →

How NXGLW scores on the Medical Devices & Diagnostics defenses

Pricing Power & Consumable Moat

Score 26 · 25% of the moat score

In MedTech, pricing power is rarely about the machine — it is about what the machine consumes.

R&D Pipeline & Capital Returns

Score 31 · 20% of the moat score

Research spending is how a device company keeps its installed base current, but spending alone proves nothing.

FCF Quality & Cash Conversion

Score 60 · 20% of the moat score

MedTech companies grow by acquisition, and the resulting intangible amortisation depresses reported earnings without consuming any cash.

Commercial Execution

Score 57 · 15% of the moat score

Devices are sold into hospitals and labs through committees, tenders and long qualification cycles, which makes the sales organisation expensive and hard to replicate.

Capital Structure & Resilience

Score 17 · 12% of the moat score

Serial acquirers carry debt, and the question is whether the cash flows underneath it are dependable enough to service it through a downturn.

Growth Durability

Score 31 · 8% of the moat score

Growth durability separates an expanding installed base from a good product cycle.

How each Medical Devices & Diagnostics defense is measured, in full →

Understanding NXGLW's moat

What is NexGel, Inc Warrant's moat score?

NexGel, Inc Warrant (NXGLW) scores 38 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as developing. It ranks #43 of 62 scored companies in Medical Instruments & Supplies, the top 69%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 61 companies in Medical Instruments & Supplies. Its strongest defense is FCF Quality & Cash Conversion (60/100) and its weakest is Capital Structure & Resilience (17/100).

How does NexGel, Inc Warrant compare with other Medical Instruments & Supplies companies?

NexGel, Inc Warrant ranks #43 of 62 scored companies in Medical Instruments & Supplies by moat score. The widest moat in Medical Instruments & Supplies is Intuitive Surgical, Inc. (ISRG) at 86/100. The companies ranked closest are NexGel, Inc (NXGL) at 38 just above it and Harvard Bioscience, Inc. (HBIO) at 37 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Medical Devices & Diagnostics in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 61 companies in Medical Instruments & Supplies. The defenses are then weighted to produce the overall score out of 100.

Why is NexGel, Inc Warrant scored with the Medical Devices & Diagnostics template?

Medical device and diagnostics companies place an instrument once and then sell the consumables, reagents and service that instrument needs for the next decade. The economics are a razor-and-blade model wrapped in regulatory approval and clinician habit, so the MedTech template scores the durability of that installed base rather than the size of any single product launch.

Which competitive defenses are measured for NexGel, Inc Warrant?

The Medical Devices & Diagnostics template measures 6 defenses, and NXGLW scores: Pricing Power & Consumable Moat (26), R&D Pipeline & Capital Returns (31), FCF Quality & Cash Conversion (60), Commercial Execution (57), Capital Structure & Resilience (17), Growth Durability (31). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000